PECULIARITIES OF THE COMBINED COURSE OF CHRONIC OBSTRUCTIVE PULMONARY DISEASE AND HYPERTENSION
DOI:
https://doi.org/10.11603/1681-2786.2017.4.8649Keywords:
chronic obstructive pulmonary disease, hypertension, sex.Abstract
The aim of the study was to analyze the features of the combined course of chronic obstructive pulmonary disease of stage II and hypertension (HT) of stage II in the gender aspect.
Materials and methods. In retrospect, 420 of patients' case histories were analyzed with the diagnosis of chronic obstructive pulmonary disease (COPD) during 2014 and 2016.
Results. Among patients with COPD, male subjects predominated (65,95 %). The gender distribution of patients with stage II COPD is as follows: male – 59,86 %, female – 40,14 %.
Conclusions. Among patients with stage II COPD 28,67 % of patients had no concomitant pathology, 27,27 % - COPD was combined with stage II hypertension, 43,36 % - COPD combined with other diseases. The analysis of the obtained data on gender indicates the predominance in male the comorbidity of COPD with other pathologies, most often (in 33 % of patients) with hypertensive disease. In female patients suffering from COPD, in addition to hypertension, there was a high incidence of coronary heart disease and endocrine system diseases.
References
Ivanovskiy, M.O., & Yushmanova, T.N. (2008). Izmenenie harakteristik mikrososudistogo krovotoka v tkanyah parodonta pod vliyaniem kureniya [Changes in the characteristics of microvascular blood flow in periodontal tissues under the influence of smoking]. Ekologiya cheloveka – Human Ecology, 3, 23-28 [in Russian].
Orehova, L.Yu., Shaporova, N.L., & Kosova, E.V. (2008). Sostoyanie tkaney parodonta u kuryaschih patsientov s hronicheskoy obstruktivnoy boleznyu legkih [Condition of periodontal tissues in smokers with chronic obstructive pulmonary disease]. Parodontologiya – Periodontology, 1, 12-17 [in Russian].
Skorochennia poshyrenosti kurinnia v Ukraini pryzvelo do skorochennia chysla vyklykanykh tiutiunom khvorob ta smertei. Pres-sluzhba MOZ Ukrainy [Reducing the prevalence of smoking in Ukraine has led to a reduction in the number of tobacco-related illnesses and deaths. Press service of the Ministry of Health of Ukraine]. (2012). www.moz.gov.ua. Retrieved from http://www.moz.gov.ua/ua/portal/pre_20120403_1.html
Mikkelsen, R.L., Middelboe, Т., Pisinger, С., et al. (2004). Anxiety and depression in patients with chronic obstructive pulmonary disease (COPD). Nord J Psychiatry, 58, 65-70.
Barnes, P.J., & Celli, B.R. (2009). Systemic manifestations and comorbidities of COPD. Eur Respir J, 33, 1165-1185.
Cao, C., Wang, R., Wang, J.M., et al. (2012). Body mass index and mortality in chronic obstructive pulmonary disease: a meta-analysis. PloS One, 7, 8.
Guo, Y., Zhang, T., Wang, Z., Yu, F., Xu, Q., Guo, W., … He, J. (2016). Body mass index and mortality in chronic obstructive pulmonary disease: A dose–response meta-analysis. Medicine, 95 (28), e4225.
Bonfield, T.L., & Caplan, A.I. (2010). Adult mesenchymal stem cells: an innovative therapeutic for lung diseases. Discov Med, 9 (47), 337-345.
Brown, C.A., Crombie, I.K., & Tunstall-Pedoe, H. (1994). Failure of cigarette smoking to explain international differences in mortality from chronic obstructive pulmonary disease. Epidemiology Community Health, 48, 134-139.
Falk, J.A., Kadiev, S., Criner, G.J., et al. (2008). Cardiac disease in chronic obstructive pulmonary disease. Proc Am Thorac Soc, 5, 543-548.
Mannino, D.M. Homa, D.M., Akinbami, L.J., et al. (2002). Chronic obstructive pulmonary disease surveillance – United States, 1971–2000. Morbidity and Mortality Weekly Report Surveillance Summaries, 51, 1-18.
Divo, М., Cote, С., Torres, J.P. et al. (2012). Comorbidities and risk of mortality in patients with chronic obstructive pulmonary disease. Am J Respir Crit Care Med, 186, 155-161.
Divo, M.J., Cabrera, C., Casanova, C., et al. (2014). Comorbidity distribution, clinical expression and survival in COPD patients with different body mass index. J COPD F, 1 (2), 229-238.
Sidney, S., Sorel, М., Quesenberry, С.Р., et al. (2005). COPD and incident cardiovascular disease hospitalizations and mortality: Kaiser Permanente Medical Care Program. Chest, 128, 2068-2075.
Fabbri, L.M., & Rabe, K.F. (2007). From COPD to chronic systemic inflammatory syndrome? Lancet, 370, 797-799.
Huiart, L., Ernst, Р., & Suissa, S. (2005). Cardiovascular morbidity and mortality in COPD. Chest, 128, 2640-2646.
Kern, E. (2011). Metabolic syndrome and systemic inflammation in COPD. COPD, 8 (6), 395-396.
Agustí, A., Barberà, J.A., Wouters, E.F.M., Peinado, V.I., & Jeffery, P.K. (2013). Lungs, bone marrow, and adipose tissue. A network approach to the pathobiology of chronic obstructive pulmonary disease. Am J Respir Crit Care Med, 188 (12), 1396-1406.
D'Agostino, R.B., Parise, H., Sullivan, L., & Meigs, J.B. (2005). Metabolic syndrome as a precursor of cardiovascular disease and type 2 diabetes mellitus. Circulation, 112 (20), 3066-3372.
Michaud, C.M., Murray, C.J., & Bloom, B.R. (2001). Burden of disease – implications for future research. JAMA, 285, 535-539.
Miniño, A.M., Xu, J.Q., & Kochanek, K.D. (2010). Deaths: Preliminary data for 2008. National Vital Statistics Reports, 59, 2-8.
Sin, D.D., Anthonisen, N.R., Soriano, J.B., et al. (2006). Mortality in COPD: Role of comorbidities. Eur Respir J, 28 (6), 1245-1257.
Murray, C.J., & Lopez, А. (1997). Alternative projections of mortality and disability by cause 1990-2020: Global Burden of Disease Study. Lancet, 349, 1498-1504.
Rubinsztajn, R., & Chazan, R. (2011). Mortality and comorbidity in hospitalized chronic obstructive pulmonary disease patients. Pneumonol Alergol Pol, 79 (5), 343-346.
Sevenoaks, M.J., & Stockley, R.A. (2006). Chronic obstructive pulmonary disease, inflammation and co-morbidity – a common inflammatory phenotype? Respiratory Research, 7, 70.
Celli, B.R., Cote, C.G., Marin, J.M., et al. (2004). The body-mass index, airflow obstruction, dyspnea, and exercise capacity index in chronic obstructive pulmonary disease. N Engl J Med, 350 (10), 1005-1012.
Sag, C., Ozden, F.O., Acikgoz, G., & Anlar, F.Y. (2007). The effects of combination treatment with a long-acting beta2-agonist and a corticosteroid on salivary flow rate, secretory immunoglobulin A, and oral health in children and adolescents with moderate asthma: a 1-month, single-blind clinical study. Clin Ther, 29, 2236-2242.
Tiengo, A., Fadini, G.P., & Avogaro, A. (2008). The metabolic syndrome, diabetes and lung dysfunction. Diabetes Metab J, 34 (5), 447-454.
Farsang, C., Kiss, I., Tykarski, A., Narkiewicz, K. (2013). Treatment of Hypertension in Patients with Chronic Obstructive Pulmonary Disease (COPD). Journal fur Hypertonie, 17 (4), 163-165.
Schols, A.M., Slangen, J., Volovics, L., & Wouters, E.F. (1998). Weight loss is a reversible factor in the prognosis of chronic obstructive pulmonary disease. Am J Respir Crit Care Med, 157 (6 Pt 1), 1791-1797.
Downloads
Published
How to Cite
Issue
Section
License
Authors who publish in this journal agree to the following terms:
1. The authors reserve the right to authorship of the work and pass the journal right of first publication of this work is licensed under a Creative Commons Attribution License, which allows others to freely distribute the work published with reference to the authors of the original work and the first publication of this magazine.
2. Authors are entitled to enter into a separate agreement on additional non-exclusive distribution of work in the form in which it was published in the magazine (eg work place in the electronic repository institution or publish monographs in part), provided that the reference to the first publication of this magazine.
3. Policy magazine allows and encourages authors placement on the Internet (eg, in storage facilities or on personal websites) manuscript of how to submit the manuscript to the editor and during his editorial processing, since it contributes to productive scientific discussion and positive impact on the efficiency and dynamics of citing published work (see. The Effect of Open Access).
